Top Upgrades

  • Morgan Stanley upgraded Alnylam Pharmaceuticals, Inc. ALNY from Equal-Weight to Overweight. Alnylam Pharmaceuticals shares rose 3.7 percent to $88.10 in pre-market trading.
  • Macquarie upgraded Encana Corp ECA from Neutral to Outperform. Encana shares rose 0.6 percent to $7.28 in pre-market trading.
  • Bank of America upgraded Veritiv Corp VRTV from Neutral to Buy. Veritiv shares fell 1.89 percent to close at $26.94 on Monday.
  • JP Morgan upgraded Ctrip.Com International Ltd CTRP from Neutral to Overweight. Ctrip.com shares rose 11.4 percent to $38.96 in pre-market trading.
  • Morgan Stanley upgraded ImmunoGen, Inc. IMGN from Underweight to Equal-Weight. Immunogen shares rose 3.1 percent to $2.68 in pre-market trading.
  • JP Morgan upgraded TPI Composites Inc TPIC from Neutral to Overweight. TPI Composites shares fell 4.11 percent to close at $27.50 on Monday.

 

Top Downgrades

  • Seaport Global downgraded Spirit AeroSystems Holdings, Inc. SPR from Buy to Neutral. Spirit AeroSystems shares fell 0.71 percent to close at $98.64 on Monday.
  • DA Davidson downgraded Inter Parfums, Inc. IPAR from Buy to Neutral. Inter Parfums shares closed at $76.80 on Monday.
  • H.C. Wainwright downgraded Evoke Pharma Inc EVOK from Buy to Neutral. Evoke Pharma shares rose 2.3 percent to $1.33 in pre-market trading.
  • Stifel Nicolaus downgraded Bluegreen Vacations Corp BXG from Buy to Hold. Bluegreen Vacations shares fell 1 percent to $15.61 in pre-market trading.
  • Leerink Swann downgraded bluebird bio Inc BLUE from Outperform to Market Perform. bluebird shares fell 1.9 percent to $150.00 in pre-market trading.
  • SVB Leerink downgraded Nightstar Therapeutics PLC NITE from Outperform to Market Perform. Nightstar Therapeutics shares closed at $25.18 on Monday.
  • Cowen & Co. downgraded Adamas Pharmaceuticals Inc ADMS from Outperform to Market Perform. Adamas Pharmaceuticals shares fell 34.2 percent to $8.00 in pre-market trading.
  • Wells Fargo downgraded Uniti Group Inc UNIT from Market Perform to Underperform. Uniti shares fell 8.1 percent to $8.73 in pre-market trading.
  • Mizuho downgraded Nightstar Therapeutics PLC NITE from Buy to Neutral. Nightstar Therapeutics shares closed at $25.18 on Monday.

 

Top Initiations

  • SVB Leerink initiated coverage on Gossamer Bio Inc GOSS with an Outperform rating. Gossamer Bio shares closed at $22.83 on Monday.
  • Analysts at Jefferies initiated coverage on Marinus Pharmaceuticals Inc MRNS with a Buy rating. The price target for Marinus Pharmaceuticals is set to $10. Marinus Pharmaceuticals shares closed at $3.56 on Monday.
  • Stephens & Co. initiated coverage on Tyson Foods, Inc. TSN with an Overweight rating. Tyson shares closed at $62.26 on Monday.
  • Needham initiated coverage on Alphabet Inc GOOGL with a Buy rating. The price target for Alphabet is set to $1,350. Alphabet shares closed at $1,153.42 on Monday.
  • Goldman Sachs initiated coverage on Lennox International Inc. LII with a Neutral rating. The price target for Lennox is set to $236. Lennox shares closed at $245.41 on Monday.
  • Analysts at Stephens & Co. initiated coverage on Pilgrim's Pride Corporation PPC with an Overweight rating. The price target for Pilgrim's Pride is set to $26. Pilgrim's Pride shares closed at $19.75 on Monday.
  • Cowen & Co. initiated coverage on Heico Corp HEI with a Market Perform rating. The price target for Heico is set to $95. Heico shares closed at $93.10 on Monday.
  • Oppenheimer initiated coverage on Arcosa Inc ACA with an Outperform rating. The price target for Arcosa is set to $40. Arcosa shares closed at $34.88 on Monday.
  • Analysts at Cantor Fitzgerald initiated coverage on Mirati Therapeutics Inc MRTX with a Neutral rating. Mirati Therapeutics shares closed at $72.93 on Monday.
  • Analysts at Baird initiated coverage on Floor & Decor Holdings Inc FND with an Outperform rating. The price target for Floor & Decor is set to $48. Floor & Decor shares closed at $38.10 on Monday.
Market News and Data brought to you by Benzinga APIs
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!